* EC: The recommended dosage is 20 mg orally once daily in combination with pembrolizumab 200 mg administered as an intravenous infusion over 30 minutes every 3 weeks.
* RCC: The recommended dosage is: * 20 mg orally once daily with pembrolizumab 200 mg administered as an intravenous infusion over 30 minutes every 3 weeks.
* 18 mg orally once daily with everolimus 5 mg orally once daily.
Modify the recommended daily dose for certain patients with renal or hepatic impairment.
Your request will be referred to the appropriate Eisai Inc. medical professional, such as a Lenvima pharmaceutical rep; Medical Science Liaison (MSL) or medical affairs.
Need to report a Lenvima issue?
ONLINE FORMReport adverse event
Learn More
You can report a Lenvima adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
prior authorization
Lenvima Prior authorization resources
NOT PROVIDED BY BRANDComplete Letter of Medical Necessity
NOT PROVIDED BY BRANDCoverage Authorization Request
NOT PROVIDED BY BRANDCoverage Authorization Appeals
Learn More
If available, these templates are provided by the brand to help you navigate insurance, especially with newer drugs.
Benefits investigation
Lenvima Intake Form
Learn More
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
NOT PROVIDED BY BRANDReimbursement help (FRM) resources
Learn More
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
financial assistance
Lenvima Financial assistance options
Co-pay savings program
commercial only
Lenvima Intake Form
Enroll in Patient Savings Program - Only HCP Office & Speciality Pharmacies Can Enroll Patients
Learn More
Overview
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
commercial only
Lenvima Temporary Supply Program Form
Learn More
Overview
Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
100% free (outside of insurance)
Patient eligibility
HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
Typically HCP assisted enrollment (via form)
Foundation programs
under insured
no insurance
goverment insurance
65+
Eisai Patient Assistance Program Enrollment Form
Learn More
Overview
Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Lenvima Patient education
Getting started on Lenvima
NOT PROVIDED BY BRANDInstructions For Use: Unresectable HCC
NOT PROVIDED BY BRANDInstructions For Use: Advanced RCC
NOT PROVIDED BY BRANDInstructions For Use: RAI-Refractory DTC
NOT PROVIDED BY BRANDInstructions For Use: Advanced Endometrial Carcinoma [Lenvima+Keytruda]
NOT PROVIDED BY BRANDInstructions For Use: Advanced RCC [Lenvima+Keytruda]
Patient toolkit
Patient Brochure: Advanced RCC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Brochure: RAI-Refractory DTC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Lenvima
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Side Effects
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
View How to Take Lenvima: Unresectable HCC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
View How to Take Lenvima: Advanced RCC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
View How to Take Lenvima: RAI-Refractory DTC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Lenvima+Keytruda: Advanced Endometrial Carcinoma & Advanced RCC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Side Effects [Lenvima+Keytruda]: Advanced Endometrial Carcinoma & Advanced RCC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
View How to Take Lenvima+Keytruda: Advanced Endometrial Carcinoma & Advanced RCC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link